Joseph France analyst

Currently out of the existing stock ratings of Joseph France, 45 are a BUY (70.31%), 19 are a HOLD (29.69%).

Joseph France

Work Performance Price Targets & Ratings Chart

Analyst Joseph France, carries an average stock price target met ratio of 65.1% that have a potential upside of 16.07% achieved within 257 days. Previously, Joseph France worked at CANTOR FITZGERALD, SEAPORT, LOOP CAPITAL.

Joseph France’s has documented 129 price targets and ratings displayed on 27 stocks. The coverage was on the Healthcare sector.

Most recent stock forecast was given on ELV, Elevance Health at 21-Apr-2023.

Wall Street Analyst Joseph France

Analyst best performing recommendations are on MOH (MOLINA HEALTHCARE).
The best stock recommendation documented was for HCA (HCA HOLDINGS) at 7/9/2021. The price target of $235 was fulfilled within 11 days with a profit of $24.78 (11.79%) receiving and performance score of 10.72.

Average potential price target upside

CI Cigna Corp CNC Centene Corp HCA HCA Holdings MOH Molina Healthcare THC Tenet Healthcare UHS Universal Health Services UNH UnitedHealth Group ACHC Acadia Healthcare Company ANTM Anthem CVS CVS Health Corp CYH Community Health Systems ENSG The Ensign Group HUM Humana CCRN Cross Country Healthcare ELV Elevance Health AMED Amedisys HR Healthcare Realty Trust USPH US Physicalrapy WBA Walgreens Boots Alliance EVHC Envision Healthcare Holdings LTC LTC Properties OHI Omega Healthcare Investors SBRA Sabra Healthcare REIT ADUS Addus HomeCare HCP Hashicorp MRT VTR Ventas

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date of last PT

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Buy Since 05-May-2026

$381

$91.43 (31.57%)

$371

21 days ago
(09-Jul-2026)

8/14 (57.14%)

$89.2 (30.57%)

259

Buy Since 18-Oct-2019

$340

$57.21 (20.23%)

$307

1 months 22 days ago
(08-Jun-2026)

11/19 (57.89%)

$50.39 (17.40%)

286

Buy Since 02-Aug-2024

$304

$21.21 (7.50%)

$310

2 months 4 days ago
(26-May-2026)

1/11 (9.09%)

$23.17 (8.25%)

191

Buy Since 23-Apr-2019

$400

$117.21 (41.45%)

$390

2 months 8 days ago
(22-May-2026)

5/7 (71.43%)

$113.76 (39.74%)

472

Buy Since 04-Nov-2024

$302

$19.21 (6.79%)

$301

2 months 10 days ago
(20-May-2026)

16/20 (80%)

$18.9 (6.68%)

436

Show more analysts

Please expand the browser size to see the chart

What Year was the first public recommendation made by Joseph France?

On 2012

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?